FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

jyothi mallajosyula

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Living Beings

Physiology

Cell Respiration

Co-author Network

Publications

TOP 3
Almas Siddiqui; Shankar J Chinta; Ingrid Hanson; jyothi mallajosyula; Simon Melov; Subramanian Rajagopolan; Anand Rane; Julie K Andersen
Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: implications for Parkinson's disease.
jyothi mallajosyula; Shankar J Chinta; Subramanian Rajagopalan; David G Nicholls; Julie K Andersen
Metabolic control analysis in a cellular model of elevated MAO-B: relevance to Parkinson's disease.
jyothi mallajosyula; Deepinder Kaur; Shankar J Chinta; Subramanian Rajagopalan; Anand Rane; David G Nicholls; Donato A Di Monte; Heather Macarthur; Julie K Andersen
MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of jyothi mallajosyula (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Almas Siddiqui; Shankar J Chinta; Ingrid Hanson; jyothi mallajosyula; Simon Melov; Subramanian Rajagopolan; Anand Rane; Julie K Andersen
Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: implications for Parkinson's disease.
Free radical biology & medicine 2012;53(4):993-1003.
2009: jyothi mallajosyula; Shankar J Chinta; Subramanian Rajagopalan; David G Nicholls; Julie K Andersen
Metabolic control analysis in a cellular model of elevated MAO-B: relevance to Parkinson's disease.
Neurotoxicity research 2009;16(3):186-93.
2008: jyothi mallajosyula; Deepinder Kaur; Shankar J Chinta; Subramanian Rajagopalan; Anand Rane; David G Nicholls; Donato A Di Monte; Heather Macarthur; Julie K Andersen
MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology.
PloS one 2008;3(2):e1616.
2007: shankar Chinta; jyothi mallajosyula; Michael Hsu; Subramanian Rajagopalan; Deepinder Kaur; Anand Rane; David G Nicholls; Jinah Choi; Julie K Andersen
Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(51):13997-4006.
2007: Deepinder Kaur; Subramanian Rajagopalan; shankar Chinta; jyothi mallajosyula; Donato A Di Monte; Robert A Cherny; Julie K Andersen
Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration.
Brain research 2007;1140():188-94.
2005: Michael Hsu; Bharath Srinivas; jyothi mallajosyula; Rajagopalan Subramanian; Julie Andersen
Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease.
Journal of neurochemistry 2005;92(5):1091-103.
2004: jyothi mallajosyula; Julie K Andersen
Perspectives on MAO-B in aging and neurological disease: where do we go from here?
Molecular neurobiology 2004;30(1):77-89.
2003: jyothi mallajosyula; David G Nicholls; Julie K Andersen
Oxidative alpha-ketoglutarate dehydrogenase inhibition via subtle elevations in monoamine oxidase B levels results in loss of spare respiratory capacity: implications for Parkinson's disease.
The Journal of biological chemistry 2003;278(47):46432-9.
2003: Deepinder Kaur; Ferda Yantiri; Subramanian Rajagopalan; jyothi mallajosyula; Jun Qin Mo; Rapee Boonplueang; Veena Viswanath; Russell Jacobs; Lichuan Yang; M Flint Beal; Dino DiMonte; Irene Volitaskis; Lisa M Ellerby; Robert A Cherny; Ashley I Bush; Julie K Andersen
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.
Neuron 2003;37(6):899-909.
2002: Nandita Jha; jyothi mallajosyula; Rapee Boonplueang; Julie K Andersen
Glutathione decreases in dopaminergic PC12 cells interfere with the ubiquitin protein degradation pathway: relevance for Parkinson's disease?
Journal of neurochemistry 2002;80(4):555-61.
2001: Julie K Andersen; jyothi mallajosyula; B Srinivas; Deepinder Kaur; Michael Hsu; Subramanian Rajagopalan
The hunt for a cure for Parkinson's disease.
Science of aging knowledge environment : SAGE KE 2001;2001(1):re1.
2000: jyothi mallajosyula; M S Jamaluddin; Krishnamurthy Natarajan; Deepinder Kaur; Asis Datta
The inducible N-acetylglucosamine catabolic pathway gene cluster in Candida albicans: discrete N-acetylglucosamine-inducible factors interact at the promoter of NAG1.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(26):14218-23.